Evidence map›Paper›PMID 42683930›Full record

ArticleJournal of the American Chemical Society2026

The Biosynthesis of a Fungal Flavonoid, Chlorflavonin, Precisely Controlled by Two Types of Equilibrium States.

Sho Furumura, Taro Ozaki, Kazuya Hasegawa, Hironori Hayashi, Masao Inoue, Kaori Fujimoto, Yohei Morishita, Mitsunori Ikeguchi, Takashi Kumasaka, Eiichi N Kodama and 2 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sho FurumuraGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai980-8578, Japan.
Taro OzakiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai980-8578, Japan.ORCID 0000-0002-4673-4478
Kazuya HasegawaStructural Biology Division, Japan Synchrotron Radiation Research Institute, 1-1-1 Kouto, Sayo, Sayo, Hyogo679-5198, Japan.
Hironori HayashiDivision of Infectious Diseases, International Research Institute of Disaster Science, Tohoku University, 2-1, Seiryo-Machi, Aoba-Ku, Sendai, Miyagi980-8575, Japan.
Masao InoueGraduate School of Medical Life Science, Yokohama City University, 1-7-29, Suehiro-Cho, Tsurumi-Ku, Yokohama230-0045, Japan.
Kaori FujimotoFrontier Research Center for Advanced Material and Life Science, Faculty of Advanced Life Science, Hokkaido University, North 21 West 11, Sapporo001-0021, Japan.
Yohei MorishitaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai980-8578, Japan.ORCID 0000-0001-8442-8642
Mitsunori IkeguchiGraduate School of Medical Life Science, Yokohama City University, 1-7-29, Suehiro-Cho, Tsurumi-Ku, Yokohama230-0045, Japan.ORCID 0000-0003-3199-6931
Takashi KumasakaStructural Biology Division, Japan Synchrotron Radiation Research Institute, 1-1-1 Kouto, Sayo, Sayo, Hyogo679-5198, Japan.
Eiichi N KodamaDivision of Infectious Diseases, International Research Institute of Disaster Science, Tohoku University, 2-1, Seiryo-Machi, Aoba-Ku, Sendai, Miyagi980-8575, Japan.ORCID 0000-0002-6622-2752
Tohru TaniguchiFrontier Research Center for Advanced Material and Life Science, Faculty of Advanced Life Science, Hokkaido University, North 21 West 11, Sapporo001-0021, Japan.ORCID 0000-0002-4965-7383
Teigo AsaiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai980-8578, Japan.ORCID 0000-0002-8903-392X

Funding

Japan Agency for Medical Research and Development JP22gm1610007Japan Agency for Medical Research and Development JP25ama121001Japan Agency for Medical Research and Development JP25ama121023Japan Agency for Medical Research and Development JP25ama121038Japan Agency for Medical Research and Development JP25ama121040Japan Science and Technology Agency JPMJAN23D4Japan Science and Technology Agency JPMJFR205WJapan Science and Technology Agency JPMJSP2114Japan Society for the Promotion of Science 23K24038Japan Society for the Promotion of Science 25H01566Japan Society for the Promotion of Science JP23K07918Japan Society for the Promotion of Science JP25K01957Japan Society for the Promotion of Science London JP25KJ0585
6 · The paper itself

Abstract

Flavonoids are polyphenolic natural products predominantly isolated from plants and exhibit a diverse array of biological activities. Because they serve as important pharmaceuticals and nutraceuticals, there is a strong demand for their sustainable supply. Chlorflavonin is a rare fungal flavonoid with potent antitubercular activity. While its biosynthetic enzymes are expected to be valuable tools for application in fungal production of flavonoids, the biosynthetic pathway remains unknown. Here, we elucidate the complete biosynthetic pathway for chlorflavonin through detailed functional analysis of each biosynthetic enzyme. Previously, stepwise and straightforward introduction of 3-, 7-, and 8-methoxy; 2'-hydroxy; and 3'-chloro functionalities have been proposed. In contrast to this proposal, we uncovered an intricate biosynthetic route involving a dynamic interconversion between the 6- and 8-methoxy forms of flavonoid skeletons mediated by the chalcone isomerase CfvF and the flavin-dependent oxygenase CfvI. CfvF interconverted the 6- and 8-methoxyflavanones, likely via a chalcone intermediate. CfvI oxidized the chemically inert 2,3-double bond of flavanone, giving the hemiacetal product. Although these enzymes generate products existing in equilibrium states, respective downstream enzymes catalyze selective conversion of one specific species, facilitating smooth progression to the final product. We also solved the crystal structure of CfvK, the dehydratase that selectively converts the 8-methoxy form of the CfvI product. Through analyzing the structure complexed with its substrate and product and site-directed mutagenesis, key residues determining the substrate selectivity were identified. Our comprehensive analysis established a rational framework for preparing 46 flavonoids, including unnatural ones, setting the stage for fungal production of structurally diverse flavonoids.

Indexed as

FlavonoidsIntramolecular LyasesModels, MolecularMolecular Structurechalcone isomeraseFlavonoidsIntramolecular Lyases

Identifiers

PMID42683930
PMCPMC13587668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.